
Bayer Raises 2025 Outlook, Adds U.S. Litigation Provisions
Bayer AG Updates 2025 Financial Outlook Following Strong Pharmaceuticals Performance in H1, Ahead of Q2 Earnings Release Bayer AG has released a preliminary update on key financial performance indicators ahead of its detailed publication of second-quarter results, scheduled for Wednesday,…












